NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 147 filers reported holding NEKTAR THERAPEUTICS in Q2 2014. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $1,558,000 | +60.3% | 90,704 | +2.2% | 0.20% | -24.4% |
| Q3 2015 | $972,000 | -19.4% | 88,717 | -19.1% | 0.27% | -38.6% |
| Q1 2015 | $1,206,000 | +581.4% | 109,612 | +859.8% | 0.43% | +365.6% |
| Q4 2014 | $177,000 | -23.7% | 11,420 | -36.8% | 0.09% | +43.1% |
| Q2 2014 | $232,000 | +48.7% | 18,062 | +31.7% | 0.06% | +124.1% |
| Q4 2013 | $156,000 | -81.6% | 13,710 | -83.1% | 0.03% | -84.7% |
| Q3 2013 | $846,000 | – | 81,000 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,000,000 | $67,200,000 | 3.35% |
| First Light Asset Management, LLC | 763,403 | $25,650,000 | 3.33% |
| BRIDGER MANAGEMENT, LLC | 1,238,489 | $41,613,000 | 3.29% |
| Rhenman & Partners Asset Management AB | 734,445 | $24,677,000 | 2.89% |
| BB BIOTECH AG | 2,020,676 | $67,895,000 | 1.71% |
| Gs Investments, Inc. | 54,200 | $1,821,120,000 | 1.43% |
| Artal Group S.A. | 900,000 | $30,240,000 | 1.24% |
| Cormorant Asset Management, LP | 500,000 | $16,800,000 | 1.14% |
| TOBAM | 640,547 | $21,522,000 | 1.09% |
| Bellevue Group AG | 430,026 | $14,449,000 | 0.80% |